Zentalis Pharmaceuticals Llc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | – | – | – | -100.0% | |
| – | – | +44.1% | +240.0% | +162.1% | -2.6% | -7.2% | -42.7% | |
| – | -892.9% | – | – | – | – | – | -101.1% | |
| – | +102.9% | +121.2% | +106.8% | -1.6% | +36.1% | -28.7% | -36.0% | |
| – | +73.5% | +300.6% | +20.8% | +33.2% | +8.9% | +46.7% | -56.7% | |
| – | +96.9% | +153.6% | +82.3% | +5.0% | +31.8% | -13.7% | -40.9% | |
| – | – | – | – | – | – | – | – | |
| – | – | +86.5% | +4,828.2% | -97.7% | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | +275.0% | +2,860.0% | -166.9% | – | – | – | +149.7% | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.